MMM

ORKLA INDIA LIMITED DRHP ANALYSIS

🏢 1. Business Overview

  • Company Name: Orkla India Limited
  • Formerly: Orkla India Pvt. Ltd. and MTR Foods Pvt. Ltd.
  • Core Business:
  • Manufacturing and marketing branded packaged foods, especially spices, ready-to-eat, instant mixes, and condiments under brands like MTR and Eastern.
  • Products include blended & pure spices, masala mixes, breakfast mixes, ready meals, and sweets.
  • Geographical Presence:
  • India Revenue FY25: ₹18,721.5 million
  • Outside India Revenue FY25: ₹4,861.7 million
  • Export Markets: Middle East, North America, and parts of Asia via subsidiary Orkla IMEA Trading LLC (UAE).
  • Strategic Focus: Expansion through regional acquisitions (Eastern Condiments merger, Rasoi Magic, and BAMS Condiments) and cross-brand integration.

🌏 2. Industry & Market Overview

  • Sector: Packaged Food & Spices Industry (India)
  • Market Size (South India Packaged Spices FY24):₹120+ billion
  • Key Trends:
  • Shift from homemade to packaged spice blends for convenience.
  • Growth in exports due to diaspora demand and global interest in Indian cuisine.
  • Industry Consolidation: Larger players acquiring regional brands (Orkla–Eastern in 2021, ITC–Sunrise, Dabur–Badshah, Wipro–Nirapara).
  • Orkla’s Market Share:
  • Karnataka: 31.2% (leader)
  • Kerala: 41.8% (leader)
  • Andhra Pradesh & Telangana: 15.2% (2nd largest).

💰 3. Objects of the Issue

  • Offer Type: 100% Offer for Sale (OFS) of up to 22,843,004 equity shares (₹1 FV).
  • Selling Shareholders:
  • Orkla Asia Pacific Pte. Ltd. – 20.56 million shares
  • Navas Meeran – 1.14 million shares
  • Feroz Meeran – 1.14 million shares
  • Purpose:
  • Listing and visibility benefits.
  • No fresh issue; company will not receive proceeds, funds go to selling shareholders.

📊 4. Financial Highlights (₹ million)

ParticularsFY25FY24FY23
Revenue23,583.223,223.921,377.3
EBITDA~3,000 (est. 13% margin)~2,800~2,500
Net Profit₹1,600–1,700 (est. 7% margin)₹1,500₹1,300
EPS (₹)12.0 (post split)11.09.8
ROE / ROCE18–20%17%15%
Cash from OperationsPositive and consistent
Dividend (FY24)₹6,000 million (₹438/share pre-split)

💧 5. Cash Flow Analysis

  • Operating Cash Flow: Positive and aligned with profits.
  • Investing Cash Flow: Negative due to acquisitions (Eastern, BAMS).
  • Financing Cash Flow: Outflow due to dividend and repayment of intercompany loans.
  • No evidence of profit–cash flow mismatch.

⚠️ 6. Key Risk Factors

  • Volatile raw material costs (chilli, coriander, turmeric) impacting margins.
  • High dependence on South India (over 70% revenue).
  • No proceeds to company (entirely OFS).
  • Integration risks post multiple acquisitions (Eastern, Rasoi Magic).
  • Competition from strong FMCG peers (ITC, Everest, Aachi, Wipro, Dabur).

👥 7. Promoter & Management Analysis

  • Promoters:
  • Orkla ASA (Norway) – Ultimate Parent
  • Orkla Asia Holding AS
  • Orkla Asia Pacific Pte. Ltd.
  • Key People:
  • Atle Vidar Nagel Johansen – Chairperson
  • Sanjay Sharma – MD & CEO
  • Suniana Calapa – CFO
  • Independent Directors: Meena Ganesh, Rashmi Joshi, Shantanu Khosla
  • Promoter Holding (Pre-IPO):~85–90%
    Post-IPO: Expected ~70% after OFS.
  • No major legal or regulatory controversies found.

🤝 8. Related Party Transactions

  • Transactions with Orkla Group entities and associates like Pot Ful India Pvt. Ltd., Orkla IMEA Trading LLC, Orkla IT AS, and Orkla Procurement AS.
  • Nature: cross-charges, IT services, procurement, and shared services.
  • All on arm’s length basis, no abnormal or conflict-prone transactions reported.

⚖️ 9. Peer Comparison & Valuation

CompanyFY24 Revenue (₹ Cr)PAT MarginP/EEV/EBITDA
Everest Food Products~1,20012%70x45x
MDH (Unlisted)~2,00010%
Orkla India (MTR + Eastern)~2,3507%TBDTBD
ITC (Foods Division)Large13%30x22x

Inference: Pricing will likely be at a discount to Everest (due to lower margins but larger scale).


🚩 10. Red Flags & Governance Checks

  • Auditors (S.R. Batliboi & Associates LLP) reported no qualifications.
  • Entire IPO is OFS, no capital inflow for business.
  • Regional concentration risk in South India.
  • Dependence on few key brands (MTR & Eastern).
  • No negative cash flow or auditor resignation.
  • Not declared as a wilful defaulter; no major litigations.

🧭 Summary Verdict

AspectAssessment
Business StrengthStrong regional brands, synergy between MTR & Eastern
Financial HealthProfitable, cash-positive, moderate margins
ValuationExpected moderate P/E, likely fair-to-premium pricing
GovernanceClean audit, reputed global promoter (Orkla ASA)
Risk LevelModerate – input cost volatility & OFS-only IPO

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top